Seven Bridge Financial Group, LLC Bio N Tech Se Transaction History

Seven Bridge Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$113.32 - $241.49 $2.1 Million - $4.48 Million	-18,570 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$85.73 - $119.5 $37,978 - $52,938	-443 Reduced 2.33%	18,570 $2.03 Million
Q4 2020 Jan 19, 2021	SELL	$72.71 - $129.54 $3,635 - $6,477	-50 Reduced 0.26%	19,013 $1.55 Million
Q3 2020 Oct 22, 2020	BUY	$57.81 - $104.17 $25,205 - $45,418	436 Added 2.34%	19,063 $1.32 Million
Q2 2020 Jul 24, 2020	BUY	$38.58 - $66.74 $718,629 - $1.24 Million	18,627 New	18,627 $1.24 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.